1-3 of 3
Esteban Cvitkovic
Close
Save search
Sort by
Journal Articles

The BET Inhibitor OTX015 (MK-8628) Shows in Vivo Antitumor Activity in Combination with Additional Targeted Agents in Diffuse Large B-Cell Lymphoma (DLBCL)

Free
Eugenio Gaudio, Luciano Cascione, Maurilio Ponzoni, MD, Chiara Tarantelli, Elena Bernasconi, Maria Eugenia Riveiro, PhD, Esteban Cvitkovic, MD, Emanuele Zucca, Francesco Bertoni
Journal: Blood
Blood (2015) 126 (23): 5119.
https://doi.org/10.1182/blood.V126.23.5119.5119
Published: 2015
Journal Articles

Preclinical Evaluation of the BET-Bromodomain (BET-BRD) Inhibitor OTX015 in Leukemia Cell Lines Harboring the JAK2 V617F Mutation

Free
Maria Eugenia Riveiro, PhD, Lucile Astorgues-Xerri, PhD, Charlotte Canet-jourdan, Mohamed Bekradda, MD, Esteban Cvitkovic, MD, Patrice Herait, MD, Eric Raymond, MD PhD
Journal: Blood
Blood (2014) 124 (21): 873.
https://doi.org/10.1182/blood.V124.21.873.873
Published: 2014
Journal Articles

The Brd-Inhibitor OTX015 Shows Pre-Clinical Activity in Anaplastic Large T-Cell Lymphoma (ALCL)

Free
Michela Boi, Paola Bonetti, PhD, Maurilio Ponzoni, Maria Grazia Tibiletti, Anastasios Stathis, MD, Esteban Cvitkovic, MD, Giorgio Inghirami, Emanuele Zucca, MD, Francesco Bertoni, MD
Journal: Blood
Blood (2012) 120 (21): 4872.
https://doi.org/10.1182/blood.V120.21.4872.4872
Published: 2012